Home/Filings/4/0001562180-23-003794
4//SEC Filing

Favorite Annette F 4

Accession 0001562180-23-003794

CIK 0000105770other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 1:53 PM ET

Size

12.1 KB

Accession

0001562180-23-003794

Insider Transaction Report

Form 4
Period: 2023-05-01
Favorite Annette F
Sr. VP & Chief HR Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-05-0113,0120 total
    Exercise: $59.64From: 2017-02-23Exp: 2026-02-23Common Stock (13,012 underlying)
  • Sale

    Common Stock

    2023-05-01$365.47/sh9,425$3,444,53918,463.962 total
  • Sale

    Common Stock

    2023-05-01$366.46/sh2,687$984,68715,776.962 total
  • Exercise/Conversion

    Common Stock

    2023-05-01$59.64/sh+13,012$776,03627,888.962 total
  • Sale

    Common Stock

    2023-05-01$367.45/sh900$330,70714,876.962 total
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $365.00 USD to $365.97 USD; the price reported above reflects the weighted average sale price.
  • [F2]This transaction was executed in multiple trades at prices ranging from $366.01 USD to $366.985 USD; the price reported above reflects the weighted average sale price.
  • [F3]This transaction was executed in multiple trades at prices ranging from $367.03 USD to $367.98 USD; the price reported above reflects the weighted average sale price.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001654975

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 1:53 PM ET
Size
12.1 KB